Cite Filings / AVTX / 0001950047-26-008220
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Avalo Therapeutics, Inc. · Filed 2026-08-17 · Acc 0001950047-26-008220

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-08-19 4 Chief Medical Officer sold 1,000 shares at $20.00 ($20,000)
  • 2026-08-19 4 Chief Financial Officer sold 72,725 shares at an average $19.94 ($1,450,419)
  • 2026-08-18 144 Sale of Securities
  • 2026-08-17 144 Sale of Securities
  • 2026-08-17 144 Sale of Securities
  • 2026-08-17 144 Sale of Securities
  • 2026-08-11 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…